Refika Yigit

Refika Yigit is an Assistant Professor in the Department of Gynecological Oncology at the University of Groningen's Faculty of Medical Sciences. She is a prominent researcher specializing in women's cancers, particularly ovarian and cervical cancer, with significant contributions to genetic testing protocols and therapeutic vaccine development.

• Active researcher in gynecological oncology since at least 2025
• Member of multiple collaborative Dutch research consortia
• Contributor to UN Sustainable Development Goals through cancer research

Dr. Yigit's research focuses on critical areas of women's oncology including BRCA1/2 genetic testing protocols, ovarian cancer biobanking initiatives, and therapeutic HPV vaccine development. Her work spans both clinical implementation studies and basic translational research, with particular emphasis on improving genetic testing workflows and developing novel interventions for precancerous cervical lesions.

Her recent publications demonstrate a strong trend toward implementing precision medicine approaches in gynecological oncology, with multiple studies focused on optimizing genetic testing protocols and evaluating novel therapeutic interventions. The research spans epidemiological studies, clinical implementation research, and phase II clinical trials, reflecting a comprehensive approach to advancing women's cancer care.

Dr. Yigit has been featured in international media as an expert commentator on HPV vaccine research, with coverage in multiple languages including English, Spanish, German, and Dutch, highlighting the global impact of her work.

As evidenced by her collaborative publications, Dr. Yigit works extensively with major Dutch cancer research networks including the Archipelago of Ovarian Cancer Research Consortium and the HEBON Investigators group, contributing to nationwide initiatives that are shaping cancer care standards in the Netherlands.